
The Debate Over Age Verification in the Hemp-THC Market
Examining the lack of regulatory oversight in hemp-derived THC sales
Multi-state cannabis operators are urging federal action to close regulatory gaps that allow hemp-derived THC products to be sold without the age verification requirements that apply to alcohol and licensed cannabis.
The concern: intoxicating hemp products containing Delta-8 THC and other compounds can be purchased by minors at gas stations, convenience stores, and online retailers with minimal or no age checks.
Licensed cannabis dispensaries, by contrast, face strict age verification requirements and significant penalties for selling to anyone under 21.
The Hemp Loophole
The 2018 Farm Bill legalized hemp and hemp derivatives containing less than 0.3% Delta-9 THC. But manufacturers have exploited this by producing intoxicating products using Delta-8 THC, Delta-10 THC, THC-O, and other compounds not explicitly prohibited.
These products aren't subject to the same regulations as state-legal cannabis:
- No license required to sell
- No testing requirements
- No potency limits
- No packaging and labeling standards
- No age verification mandates in most states
The result is what industry critics call an unregulated intoxicating market operating alongside heavily regulated state cannabis programs.
MSO Concerns
Licensed cannabis operators argue the disparity creates unfair competition while raising public safety concerns. They're subject to extensive regulations and compliance costs while hemp sellers face minimal oversight.
More importantly, the lack of age checks means intoxicating products are accessible to minors—exactly what state cannabis regulations are designed to prevent.
"The U.S. has the infrastructure and experience to implement effective age verification measures for hemp-derived products," industry representatives argue, pointing to established systems for alcohol and tobacco.
State Responses
Some states have moved to regulate hemp-derived THC products, either banning them entirely or bringing them under existing cannabis regulations. But the patchwork of state approaches creates confusion and compliance challenges.
Federal action would provide consistency, but Congress hasn't moved to close the loophole despite growing concerns from both cannabis industry stakeholders and some public health advocates.
What's Needed
Industry groups are pushing for federal hemp regulations that would:
- Require age verification for intoxicating hemp products
- Establish testing and labeling standards
- Set potency limits
- Create accountability for manufacturers and retailers
Until such regulations exist, the hemp-derived THC market will continue operating with minimal oversight while state-licensed cannabis businesses navigate comprehensive regulatory frameworks.
This article is based on original reporting by High Times.
Original Source
This article is based on reporting from High Times.
Read the original articleOriginal title: "America Cards You for Beer. So Why Can’t It Card for Hemp-THC?"
Related Topics
Related Stories
LegislationMassachusetts Halts Cultivation Licenses as Prices Drop to $14/Eighth
Massachusetts Cannabis Control Commission approved a four-month freeze on new cultivation licenses starting June 16, responding to oversupply that's pushed retail prices down to $14 per eighth-ounce.
LegislationTrump Executive Order Fast-Tracks Psychedelic Research Access
Trump's executive order directs federal agencies to fast-track psychedelic research and clinical access programs for mental health treatment, though implementation faces similar regulatory hurdles that have complicated cannabis reform.
Industry NewsIndustry Veteran Calls for Unified Cannabis and Hemp Regulations
Cannabis entrepreneur Jason Leisey argues that maintaining separate regulatory standards for marijuana and hemp products creates dangerous loopholes that threaten consumer trust and industry credibility.
More from Alex Morgan
View all articles
Massachusetts Halts Cultivation Licenses as Prices Drop to $14/Eighth

Spain's Cannabis Concentrate Market Shifts From BHO to Rosin

Trump Publicly Pressures DOJ on Marijuana Rescheduling Delays

